9 results
Prostanoid prescribing and management in Pulmonary Arterial Hypertension (PAH)
Oral Prostanoids:
 - Selexipag
 - Treprostinil
Inhaled Prostanoids
 -
in Pulmonary Arterial ... Hypertension (PAH ... #PAH #Management ... #Algorithm #treatment ... #pharmacology
Low / Intermediate Risk Pulmonary Arterial Hypertension (PAH) Management Algorithm

Dr. John Ryan @JJRyanMD

#Pulmonary #Arterial #Hypertension #PAH
(PAH) Management ... Algorithm Dr. ... #PAH #Management ... #Algorithm #treatment ... #pharmacology
High Risk Pulmonary Arterial Hypertension (PAH) Management Algorithm

Dr. John Ryan @JJRyanMD

#Pulmonary #Arterial #Hypertension #PAH #Management #Algorithm
High Risk Pulmonary ... (PAH) Management ... Algorithm Dr. ... #PAH #Management ... #Algorithm #treatment
Treatment of Stable Narrow-Complex Tachycardia
Regular Rhythm:
 • Attempt vagal maneuvers
 • Give adenosine 6 milligrams IV
Treatment of Stable ... Treat underlying cause ... Treat underlying cause ... #management #cardiology ... #algorithm
Portopulmonary Hypertension
Presence of pulmonary arterial hypertension in a patient with portal hypertension
No other obvious causes (chronic
arterial hypertension ... other obvious causes ... 3 Woods units, PA ... pressure < 15mmHg TREATMENT ... Hypertension #diagnosis #management
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
with presence of pulmonary ... the determined cause ... #differential #algorithm ... #management #cardiology ... icu #clinical #pharmacology
Immune Reconstitution Inflammatory Syndrome - Overview of IRIS

What Is IRIS?
	• A state of hyperinflammatory response that
Lymphadenitis, pulmonary ... lymphadenitis, pulmonary ... , hypoxia, and pulmonary ... leukoencephalopathy (PML), Confusion ... Differential #Diagnosis #Management
The crusade against “Ab”Normal Saline continues.  This is a non-physiologic fluid that can harm our
K+ in the ECF causes ... of the afferent arteriole ... #criticalcare #management ... #diagnosis #treatment ... #pharmacology #
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
, INC risk PE, Pulmonary ... amyloidosis, PAH ... Adenocarcinoma Treatment ... lubricants • Pharmacologic ... Rheumatology #Diagnosis #Management